JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB141265

Pargyline hydrochloride, Monoamine oxidase (MAO) inhibitor

Be the first to review this product! Submit a review

|

(2 Publications)

MW 195.69 Da, Purity >99%. Monoamine oxidase (MAO) inhibitor (IC50 = 0.9 μM). Orally active in vivo.
1 Images
Chemical Structure - Pargyline hydrochloride, Monoamine oxidase (MAO) inhibitor (AB141265)
  • Chemical Structure

Lab

Chemical Structure - Pargyline hydrochloride, Monoamine oxidase (MAO) inhibitor (AB141265)

2D chemical structure image of ab141265, Pargyline hydrochloride, Monoamine oxidase (MAO) inhibitor

Key facts

CAS number

306-07-0

Purity

>99%

Form

Solid

form

Molecular weight

195.69 Da

Molecular formula

C<sub>1</sub><sub>1</sub>H<sub>1</sub><sub>4</sub>ClN

PubChem

9373

Nature

Synthetic

Solubility

Soluble in water to 100 mM

Soluble in ethanol to 100 mM

Biochemical name

Pargyline hydrochloride

Biological description

Monoamine oxidase (MAO) inhibitor (IC50 = 0.9 μM). Orally active in vivo.

Canonical smiles

CN(CC#C)CC1=CC=CC=C1.Cl

InChi

InChI=1S/C11H13N.ClH/c1-3-9-12(2)10-11-7-5-4-6-8-11;/h1,4-8H,9-10H2,2H3;1H

InChiKey

BCXCABRDBBWWGY-UHFFFAOYSA-N

IUPAC Name

N-benzyl-N-methylprop-2-yn-1-amine;hydrochloride

style
left-column
style
left-column

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
style
left-column
style
left-column
style
left-column

Product protocols

style
left-column

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Science advances 10:eadp6301 PubMed39565858

2024

Reduced striatal M4-cholinergic signaling following dopamine loss contributes to parkinsonian and l-DOPA-induced dyskinetic behaviors.

Applications

Unspecified application

Species

Unspecified reactive species

Beatriz E Nielsen,Christopher P Ford

Frontiers in bioengineering and biotechnology 12:1335474 PubMed38328444

2024

Continuous long-range measurement of tonic dopamine with advanced FSCV for pharmacodynamic analysis of levodopa-induced dyskinesia in Parkinson's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Jeongrak Park,Seongtak Kang,Yaebin Lee,Ji-Woong Choi,Yong-Seok Oh
View all publications
style
left-column
style
left-column
style
right-column

Complementary Products

Primary Antibodies

AB66047

Anti-Serotonin antibody

  • 5
  • 4
Primary Antibodies

AB137869

Anti-Tyrosine Hydroxylase antibody [EP1532Y] - Neuronal Marker

RabMAb|Recombinant|Lab Essentials|20ul selling size

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tyrosine Hydroxylase antibody [EP1532Y] - Neuronal Marker (AB137869)

  • 5
  • 9
Primary Antibodies

AB270993

Anti-Collagen I antibody [EPR24331-53]

BOND RX™ Validated|RabMAb|Recombinant|Lab Essentials|20ul selling size|Advanced Validation

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Collagen I antibody [EPR24331-53] (AB270993)

  • 1
  • 1
Primary Antibodies

AB182136

Anti-beta 2 Adrenergic Receptor antibody [EPR707(N)]

BOND RX™ Validated|20ul selling size|RabMAb|Recombinant

Immunohistochemistry (Frozen sections) - Anti-beta 2 Adrenergic Receptor antibody [EPR707(N)] (AB182136)

  • 4
  • 5

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com